Clinical Trials and Cohort Studies Grants support high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health.
The desired outcomes of Clinical Trials and Cohort Studies Grants opportunity are improvements in health and well-being, health care practice or policy, as a result of:
- high-quality clinical trials that provide reliable evidence of the effects of health-related interventions on health outcomes (or appropriate surrogates), and/or
- high-quality cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes.
Clinical Trials and Cohort Studies Grants may be funded by or in conjunction with other organisations. These grants offer opportunities to researchers whose work is particularly relevant to the priorities and research interests of the partner organisations.
Information on how organisations and individuals can support NHMRC to fund health and medical research is available on the .
2019 Funding Round – Soft Opening
The following documentation is currently available from the Clinical Trials and Cohort Studies Grants 2019 Forecast Opportunity on GrantConnect:
- Clinical Trials and Cohort Studies Grants 2019 Guidelines
- Clinical Trials and Cohort Studies Grants 2019 Guide to Applicants, including the Category Descriptors.
This information will assist applicants to begin preparing their application in advance of the funding opportunity opening on 6 March 2019.
The full suite of documentation required to apply will become available once the funding opportunity opens.